Advertisement

Topics

Deal Watch: Takeda Teams With Molecular Templates On Anti-CD38 Approach To Multiple Myeloma

14:28 EDT 20 Sep 2018 | SCRIP

Takeda and Molecular Templates will work to develop targeted engineered toxin bodies for multiple myeloma. Celgene decides against optioning OncoMed’s...

      

Related Stories

 

Original Article: Deal Watch: Takeda Teams With Molecular Templates On Anti-CD38 Approach To Multiple Myeloma

NEXT ARTICLE

More From BioPortfolio on "Deal Watch: Takeda Teams With Molecular Templates On Anti-CD38 Approach To Multiple Myeloma"

Advertisement
Quick Search
Advertisement
Advertisement